In STZ-treated 3×Tg-AD, SG-Tang treatment further improved working and spatial memories (Figure 4), reduced abnormal accumulations of Aβ and Tau (Figure 5), as well as down-regulated NLRP1/NLRP3 (Figure 6). This evidence concerns the gene NLRP3 and Alzheimer disease.